Osphos Survey Winner Scoops £250 Prize
8 years ago 
1369 views
A Cheshire vet has won a £250 prize from Dechra Veterinary Products after completing a feedback survey about one of its leading equine treatments.
Osphos, an intramuscular Clodronic acid injection, is the only UK veterinary licensed product for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses.
Elen Lawton, who works for Wright & Morten Veterinary Surgery and specialises in equine orthopaedics, won the voucher to spend at retailer Joules for entering the survey about Osphos.
Alana McGlade, Equine Technical Sales Manager at Dechra Veterinary Products, said: “Feedback surveys are an important way for us to gather information on our product range, resources and the experience we offer our customers.
“Osphos is a key treatment in our equine portfolio so the results from the survey provide us with a valuable insight into customer needs.”
Clinical trials have shown that Osphos is a very effective treatment. It is well tolerated and has a proven efficacy in tests performed at six months’ post treatment - 74.7 per cent of horses experienced improvement by at least one lameness grade at 56 days post treatment.¹
For further information, visit www.dechra.co.uk.
¹ Frevel et al (2014) Multi-centre field trial to evaluate the effectiveness of clodronic acid for navicular syndrome, Equine Veterinary Journal 46, Suppl. 47, 5-6.
More from Dechra
